Key result
Primary systemic AL-amyloidosis presents atypically with initial pleuropulmonary involvement before progressing to cardiorenal injury.
Why the study?
AL-amyloidosis typically leads to restrictive cardiomyopathy and kidney involvement, making cases that present initially with lung and pleural involvement before progressing to heart and kidney injury unusual.
Case Report (n=1)
This case report highlights an unusual presentation of primary systemic AL-amyloidosis initially affecting the lungs and pleura before causing cardiac and renal injury.
Answers are grounded in this paper and cite their sources.
Tissue biopsy remains essential for AL-amyloidosis diagnosis; leaves open non-invasive alternatives for routine screening.
AL-amyloidosis is a disease associated with the clonal plasma cell proliferation and aberrant immunoglobulin light chain secretion. Deposition of insoluble polymers composed of monoclonal light chain lead to disruption of tissue architecture and organ dysfunction. Infiltrative amyloidogenesis often results in restrictive cardiomyopathy, leading to progressive heart failure, and kidney involvement with nephrotic proteinuria and dysfunction. Diagnostic is based on findings of tissue amyloid deposition and confirmation of monoclonal light chain nature. Here we reported course, diagnostic and successful treatment of primary AL-amyloidosis case with unusual disease presentation with lungs and pleura involvement, resulting further in heart and kidneys injuries.
No takes yet. Share an insight, caveat, or question.
Афанасьевна et al. (2017) conducted a case report in Primary systemic AL-amyloidosis (n=1). Primary systemic AL-amyloidosis presented unusually in 1 patient with initial lung and pleural involvement, subsequently progressing to cardiac and renal injury before successful treatment.
Synapse has enriched 10 related papers. Consider them for comparative context: